In Situ Study of p53, MDM2, and MDMX Protein Interaction in Living Cells Using Fluorescence Triple Correlation Spectroscopy
- 5 April 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (15) , 11298-11309
Abstract
The tumor suppressor protein p53 is a crucial transcription factor that regulates physiological processes, including apoptosis, cell cycle progression, DNA damage stress and repair, and programmed cell death. The activity of the intracellular p53 protein is tightly regulated by MDM2 and MDMX proteins. Despite significant advances in studying the interactions among p53, MDM2, and MDMX, obtaining in situ information about these interactions in living cells remains highly challenging. In this study, we proposed a new method for investigating the interaction of p53, MDM2, and MDMX in living cells by combining fluorescence triple correlation spectroscopy (FTCS) with a protein fusion labeling technique. p53, MDM2, and MDMX were fluorescently labeled by gene engineering techniques, and FTCS was used to detect triple-labeled complexes. We achieved the first in situ observation of the formation of the p53-MDM2-MDMX ternary complex in living cells and quantified the concentration distribution of the protein complex in different cellular regions. An investigation was conducted into the influences of the MDMX structure on the formation of the p53-MDM2-MDMX ternary complex. We found that the core RING domain of MDMX significantly impacts the stability of the ternary complex. Furthermore, we investigated the dissociation kinetics of the p53-MDM2-MDMX ternary complex in the presence of p53 inhibitors and developed a novel method for evaluating the inhibitor efficacy within living cells. We confirmed that the potent inhibitor RO-5963 disrupts complex stability by driving an extremely fast dissociation rate constant. Our approach is of significant importance for elucidating the mechanisms and progression of tumorigenesis.Keywords
Funding Information
- National Natural Science Foundation of China (21834005)
- National Natural Science Foundation of China (21911530144)
- National Natural Science Foundation of China (22027803)
- National Natural Science Foundation of China (22274098)
This publication has 54 references indexed in Scilit:
- Isothermal strand displacement polymerase reaction (ISDPR)-assisted microchip electrophoresis for highly sensitive detection of cancer associated microRNAsAnalytica Chimica Acta, 2024
- Structure-based discovery of novel α-aminoketone derivatives as dual p53-MDM2/MDMX inhibitors for the treatment of cancerEuropean Journal of Medicinal Chemistry, 2023
- The MDMX acidic domain competes with the p53 transactivation domain for MDM2 N-terminal domain bindingBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- Protein‐protein interaction networks as miners of biological discoveryProteomics, 2022
- Tumor suppressor p53 cross-talks with TRIM family proteinsGenes & Diseases, 2021
- Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppressionActa Pharmaceutica Sinica B, 2021
- Putting p53 in ContextCell, 2017
- p53 as guardian of the mitochondrial genomeFEBS Letters, 2016
- MDMX: a novel p53‐binding protein with some functional properties of MDM2.The EMBO Journal, 1996
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992